Interview with Fernando Pitossi, Treasurer, Instituto Leloir
The appointment of Lino Barañao and the establishment of the Ministry of Science and Technology suggest that the government has realised what a large role innovation can play in the…
Address: Av. Patricias Argentinas 435 (C1405BWE), Buenos Aires,Argentina
Tel: +54 11 5238 7500
Web: http://www.leloir.org.ar/
A world-renowned research institute, Instituto Leloir was named after the nobel-prize winning Argentinean scientist Dr Federico Leloir. Internationally assessed, the institute works in areas of pure research, and helps scientists collaborate with companies in order to provide cutting-edge innovation to both Argentinean and international companies.Instituto Leloir works alongside the Argentinean pharmaceutical industry in this capacity, and has recently begun work on an important collaboration with Pfizer into Parkinson’s research.
Research, Training, Financial Support for Scientific Community, Arrangement of contacts between companies and research scientists
The appointment of Lino Barañao and the establishment of the Ministry of Science and Technology suggest that the government has realised what a large role innovation can play in the…
“In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes about the capacity of…
The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a strong branded generics market…
When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a…
Roemmers fue establecida en 1921. ¿Cómo paso de ser una empresa familiar a la empresa que es hoy, y cuáles han sido los desafíos en el cambio en la cultura…
The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe or the United States, but in emerging…
Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately after the regulation regarding…
What have been the recent major milestones for Richmond? One of the milestones for Laboratorios Richmond was to have developed the first branded oncological generic in the world. For Laboratorios…
Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in…
What was the vision behind the creation of the umbrella organisation Amega Biotech in 2005? What led you to consider setting up an organisation with this structure, and offering these…
Do you think this is a good moment for the Argentinean pharmaceutical industry to have international exposure? Indeed it is attractive, but we should keep the long term objectives on…
Laboratorios Bernabó es una de las empresas farmacéuticas más distinguidos de toda la historia de la Argentina, con más de 70 años en el mercado. ¿Cómo ha cambiado la visión…
Argentina was home to Roche´s first Latin American subsidiary. Today, how important is Argentina for Roche worldwide? Argentina will become this year the third affiliate –after Brazil and Mexico-in terms…
See our Cookie Privacy Policy Here
